CH BIOTECH SER (08037) announced that on September 9, 2025, Pengbo (Hainan) Boron Neutron Medical Technology Co., Ltd. (Pengbo Hainan), a limited liability company incorporated in China and an indirect wholly-owned subsidiary of the Company as of the announcement date, entered into a loan agreement with Qionghai Branch of Hainan Rural Commercial Bank Co., Ltd. as the lender, acting as the borrower.

Under the agreement, the lender has agreed to provide Pengbo Hainan with a loan facility of up to RMB 180 million in principal amount. The loan will provide additional support for the construction of the Boron Neutron Capture Therapy center, with the goal of opening and commencing operations by the end of 2025 to provide boron neutron therapy services to cancer patients in need.

Leveraging the supportive policies of the Boao Lecheng pilot zone and using this center as a demonstration project, the Group is committed to developing a network of Boron Neutron Capture Therapy centers covering China in the future, developing franchise hospitals to generate additional revenue streams.